Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes

被引:0
|
作者
Wei-Bo Du
机构
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
acute on chronic liver failure; bioartificial liver; immortalized human hepatocyte; cytochrome P450; cell culture;
D O I
暂无
中图分类号
R575.3 [肝功能衰竭];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND:The bioartificial liver is anticipated to be a promising alternative choice for patients with liver failure. Toxic substances which accumulate in the patients’plasma exert deleterious effects on hepatocytes in the bioreactor,and potentially reduce the efficacy of bioartificial liver devices. This study was designed to investigate the effects of plasma from patients with acute on chronic liver failure(AoCLF)on immortalized human hepatocytes in terms of cytochrome P450 gene expression,drug metabolism activity and detoxification capability. METHODS:Immortalized human hepatocytes(HepLi-2 cells)were cultured in medium containing fetal calf serum or human plasma from three patients with AoCLF.The cytochrome P450(CYP3A5,CYP2E1,CYP3A4)expression, drug metabolism activity and detoxification capability of HepLi-2 cells were assessed by RT-PCR,lidocaine clearance and ammonia elimination assay. RESULTS:After incubation in medium containing AoCLF plasma for 24 hours,the cytochrome P450 mRNA expression of HepLi-2 cells was not significantly decreased compared with control culture.Ammonia elimination and lidocaine clearance assay showed that the ability of ammonia removal and drug metabolism remained stable. CONCLUSIONS:Immortalized human hepatocytes can be exposed to AoCLF plasma for at least 24 hours with no significant reduction in the function of cytochrome P450. HepLi-2 cells appear to be effective in metabolism and detoxification and can be potentially used in the development of bioartificial liver.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [41] Comparative analysis of monocyte-derived dendritic cell phenotype and T cell stimulatory function in patients with acute-on-chronic liver failure with different clinical parameters
    Wu, Zhipeng
    Shi, Hongbo
    Zhang, Lei
    Shi, Honglin
    Miao, Xingzhong
    Chen, Liangjuan
    Chen, Yu
    Ma, Yingmin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange
    Wang, Lu
    Zhu, Shu
    Liu, Ying
    Zheng, Lihua
    Xu, Wenxiong
    Luo, Qiumin
    Zhang, Yeqiong
    Deng, Hong
    Li, Xinhua
    Xie, Chan
    Peng, Liang
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (09) : 1089 - 1096
  • [43] iTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure
    Peng, Liang
    Liu, Jing
    Li, Yang-Mei
    Huang, Zhan-Lian
    Wang, Pei-Pei
    Zheng, Yu-Bao
    Hua, Yun-Peng
    Gao, Zhi-Liang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (05) : 1732 - 1742
  • [44] Low Volume Plasma Exchange and Low Dose Steroid Improve Survival in Patients With Alcohol-Related Acute on Chronic Liver Failure and Severe Alcoholic Hepatitis - Preliminary Experience
    Kumar, Santhosh E.
    Goel, Ashish
    Zachariah, Uday
    Nair, Sukesh C.
    David, Vinoi G.
    Varughese, Santosh
    Gandhi, Prashanth B.
    Barpha, Amit
    Sharma, Anand
    Vijayalekshmi, Balakrishnan
    Balasubramanian, Kunissery A.
    Elias, Elwyn
    Eapen, Chundamannil Eapen
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 372 - 378
  • [45] Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p
    Senquan Zhang
    Jie Yu
    Keqiang Rao
    Jie Cao
    Lijie Ma
    Yeping Yu
    Zhe Li
    Zhaokai Zeng
    Yongbing Qian
    Mo Chen
    Hualian Hang
    Hepatology International, 2023, 17 : 833 - 849
  • [46] Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p
    Zhang, Senquan
    Yu, Jie
    Rao, Keqiang
    Cao, Jie
    Ma, Lijie
    Yu, Yeping
    Li, Zhe
    Zeng, Zhaokai
    Qian, Yongbing
    Chen, Mo
    Hang, Hualian
    HEPATOLOGY INTERNATIONAL, 2023, 17 (04) : 833 - 849
  • [47] Impaired TLR3/IFN-β signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage
    Li, Ning
    Li, Qian
    Qian, Zhiping
    Zhang, Yujie
    Chen, Mingquan
    Shi, Guangfeng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (03) : 630 - 635
  • [48] Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure
    Li, Qian
    Lu, Qing
    Zhu, Meng-Qi
    Huang, Chong
    Yu, Kang-Kang
    Huang, Yu-Xian
    Zhao, Xu
    Luo, Xing-Guang
    Zheng, Jian-Ming
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [49] Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure
    Qian Li
    Qing Lu
    Meng-Qi Zhu
    Chong Huang
    Kang-Kang Yu
    Yu-Xian Huang
    Xu Zhao
    Xing-Guang Luo
    Jian-Ming Zheng
    BMC Gastroenterology, 20
  • [50] Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study
    Chen, Yuan-yuan
    Li, Hai
    Xu, Bao-yan
    Zheng, Xin
    Li, Bei-ling
    Wang, Xian-bo
    Huang, Yan
    Gao, Yan-hang
    Qian, Zhi-ping
    Liu, Feng
    Lu, Xiao-bo
    Shang, Jia
    Wang, Shao-yang
    Zhang, Yin-hua
    Meng, Zhong-ji
    FRONTIERS IN MEDICINE, 2021, 8